Author: Kissling, Esther; Hooiveld, Mariette; Sandonis MartÃn, Virginia; MartÃnez-Baz, Iván; William, Naoma; Vilcu, Ana-Maria; Mazagatos, Clara; Domegan, Lisa; de Lusignan, Simon; Meijer, Adam; Machado, Ausenda; Brytting, Mia; Casado, Itziar; Murray, Josephine-L K.; Belhillil, Sylvie; Larrauri, Amparo; O’Donnell, Joan; Tsang, Ruby; de Lange, Marit; Rodrigues, Ana Paula; Riess, Maximilian; Castilla, Jesús; Hamilton, Mark; Falchi, Alessandra; Pozo, Francisco; Dunford, Linda; Cogdale, Jade; Jansen, Tessa; Guiomar, Raquel; Enkirch, Theresa; Burgui, Cristina; Sigerson, Debbie; Blanchon, Thierry; MartÃnez Ochoa, Eva MarÃa; Connell, Jeff; Ellis, Joanna; van Gageldonk-Lafeber, Rianne; Kislaya, Irina; Rose, Angela MC; Valenciano, Marta; Andrews, Nick; Lopez Bernal, Jamie; Whitaker, Heather; Guerrisi, Caroline; Launay, Titouan; Masse, Shirley; van der Werf, Sylvie; Enouf, Vincent; Cuddihy, John; McKenna, Adele; Joyce, Michael; de Gascun, Cillian; Moran, Joanne; Miqueleiz, Ana; Navascués, Ana; Trobajo-SanmartÃn, Camino; Ezpeleta, Carmen; Moreno, Paula López; Gorricho, Javier; Ardanaz, Eva; Baigorria, Fernando; Barricarte, Aurelio; de la Cruz, Enrique; Egüés, Nerea; GarcÃa Cenoz, Manuel; Guevara, Marcela; Moreno-Iribas, Conchi; Sayón, Carmen; Gomez, Verónica; Nunes, Baltazar; Roquete, Rita; Silva, Adriana; Melo, Aryse; Costa, Inês; Verdasca, Nuno; Conde, PatrÃcia; Marques, Diogo FP; Molesworth, Anna; Quinn, Leanne; Leyton, Miranda; Campbell, Selin; Thoulass, Janine; McMenamin, Jim; Mateo, Ana MartÃnez; Basile, Luca; Castrillejo, Daniel; Quiñones Rubio, Carmen; Delgado-Sanz, Concepción; Oliva., Jesús
Title: Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 Cord-id: vnhyaqyx Document date: 2021_7_22
ID: vnhyaqyx
Snippet: We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2 cases and 4,372 test-negative controls in the main analysis. The VE was 62% (95% CI: 45–74) for one dose only and 89% (95% CI: 79–94) for complete vaccination. COVID-19 vaccines provide good protection against COVID-19 presentation at primary care
Document: We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2 cases and 4,372 test-negative controls in the main analysis. The VE was 62% (95% CI: 45–74) for one dose only and 89% (95% CI: 79–94) for complete vaccination. COVID-19 vaccines provide good protection against COVID-19 presentation at primary care/outpatient level, particularly among fully vaccinated individuals.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date